What changed at SGN in March, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
March 2026 — Vol. 3, No. 3
Page 4 of 4 of this archive, newest first.
Also filed — page 4
the rolling newsroom, March 2026Independent analysis puts a SGN survodutide lot at 95.6%, against 93.1% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
The quiet end of Calder Vale Peptides of Skipton
A proper account of an operation that existed, and of what closing it cost.
A shortage listing ends. 24 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
What a 23% rise in coupling-reagent prices does to a 2 mg vial
Follow the resin, not the catalogue.
Nigeria caps dulaglutide prescribing to 18 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
Inspectors cite the online reseller trading as Adamant Research Supply over sterility assurance
The observation that closes a facility is rarely the dramatic one.
The 12-day notice: how a compounding wind-down works in Italy
The document is four pages. Three of them are about dates.
QST declines, for the 3rd time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Italy caps exenatide prescribing to 19 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
SURMOUNT-2 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
SURMOUNT-2 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Spain health authority warns on falsified exenatide pens
Reported from the analysis, not from a warning notice.
QSC declines, for the 4th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
A shortage listing ends. 17 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
What a 35% rise in coupling-reagent prices does to a 20 mg vial
Follow the resin, not the catalogue.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
The consolidator trading as Meridian Freight Partners closes after 23 years
A proper account of an operation that existed, and of what closing it cost.